These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 2874816)
1. Crystallographic and conformational studies on histamine H1-receptor antagonists. IV. On the stereochemical vector of antihistaminic activity. Borea PA; Bertolasi V; Gilli G Arzneimittelforschung; 1986 Jun; 36(6):895-9. PubMed ID: 2874816 [TBL] [Abstract][Full Text] [Related]
2. Stereochemical diversity-oriented conformational restriction strategy. Development of potent histamine H3 and/or H4 receptor antagonists with an imidazolylcyclopropane structure. Watanabe M; Kazuta Y; Hayashi H; Yamada S; Matsuda A; Shuto S J Med Chem; 2006 Sep; 49(18):5587-96. PubMed ID: 16942032 [TBL] [Abstract][Full Text] [Related]
3. Optically active analogues of ebastine: synthesis and effect of chirality on their antihistaminic and antimuscarinic activity. Zhang MQ; Walczynski K; Ter Laak AM; Timmerman H Chirality; 1994; 6(8):631-41. PubMed ID: 7857774 [TBL] [Abstract][Full Text] [Related]
4. Quantum mechanical study on the conformational properties of antihistaminic drugs. Pullman B; Courrière P; Berthod H Mol Pharmacol; 1975 May; 11(3):268-79. PubMed ID: 238128 [No Abstract] [Full Text] [Related]
6. Lack of influence of histamine H1-, and H2-receptor antagonists on histamine level in rat brain. Zandarowska E; Nowak JZ; Bielkiewicz B Arch Immunol Ther Exp (Warsz); 1980; 28(6):931-4. PubMed ID: 6114723 [TBL] [Abstract][Full Text] [Related]
7. [Comparative antihistamine and anti-allergic effects of various antihistamine preparations]. Fridliand DG; Gushchin IS; Poroshina IuA; Shul'zhenko AE Ter Arkh; 2002; 74(3):67-72. PubMed ID: 11980129 [TBL] [Abstract][Full Text] [Related]
8. Effects of H1- and H2-antihistamines on platelet-activating factor and bradykinin-induced inflammatory responses in human skin. Sansom JE; Brooks J; Burton JL; Archer CB Clin Exp Dermatol; 1996 Jan; 21(1):33-7. PubMed ID: 8689766 [TBL] [Abstract][Full Text] [Related]
9. Effect of 1-(2-ethoxyethyl)-2-(4-methyl-1-homopiperazinyl)-benzimida zole difumarate (KB-2413), a new antiallergic, on chemical mediators. Fukuda T; Morimoto Y; Iemura R; Kawashima T; Tsukamoto G; Ito K Arzneimittelforschung; 1984; 34(7):801-5. PubMed ID: 6149754 [TBL] [Abstract][Full Text] [Related]
10. Effects of histamine and H1 and H2-receptor antagonists on wet-dog-shake episodes in rats induced with tranylcypromine and 5-methoxytryptamine. Kolasa K; Kleinrok Z; Rajtar G; Juszkiewicz M Acta Physiol Pol; 1984; 35(3):225-30. PubMed ID: 6152672 [TBL] [Abstract][Full Text] [Related]
11. [Mutagenesis of the human histamine H1 receptor and design of new antihistamine agents]. Differding E; Gillard M; Moguilevsky N; Varsalona F; Noyer M; Daliers J; Goldstein S; Neuwels M; Lassoie MA; Guillaume JP; Bascour M; Bollen A; Hénichart JP J Pharm Belg; 1996; 51(3):155-60. PubMed ID: 8778348 [TBL] [Abstract][Full Text] [Related]
12. Antimycobacterial and H1-antihistaminic activity of 2-substituted piperidine derivatives. Weis R; Schweiger K; Faist J; Rajkovic E; Kungl AJ; Fabian WM; Schunack W; Seebacher W Bioorg Med Chem; 2008 Dec; 16(24):10326-31. PubMed ID: 18977145 [TBL] [Abstract][Full Text] [Related]
13. Histamine H1-receptor antagonists inhibit nuclear factor-kappaB and activator protein-1 activities via H1-receptor-dependent and -independent mechanisms. Roumestan C; Henriquet C; Gougat C; Michel A; Bichon F; Portet K; Jaffuel D; Mathieu M Clin Exp Allergy; 2008 Jun; 38(6):947-56. PubMed ID: 18498541 [TBL] [Abstract][Full Text] [Related]
14. A kinetic study of the antihistaminic effect of terfenadine. Cheng HC; Woodward JK Arzneimittelforschung; 1982; 32(9a):1160-6. PubMed ID: 6129862 [TBL] [Abstract][Full Text] [Related]
15. Application of a mathematical topological pattern of antihistaminic activity for the selection of new drug candidates and pharmacology assays. Duart MJ; García-Domenech R; Galvez J; Aleman PA; Martín-Algarra RV; Antón-Fos GM J Med Chem; 2006 Jun; 49(12):3667-73. PubMed ID: 16759109 [TBL] [Abstract][Full Text] [Related]
16. Mizolastine: antihistaminic activity from preclinical data to clinical evaluation. Simons FE Clin Exp Allergy; 1999 Mar; 29 Suppl 1():3-8. PubMed ID: 10209699 [TBL] [Abstract][Full Text] [Related]
17. Characterization of the ocular antiallergic and antihistaminic effects of olopatadine (AL-4943A), a novel drug for treating ocular allergic diseases. Sharif NA; Xu SX; Miller ST; Gamache DA; Yanni JM J Pharmacol Exp Ther; 1996 Sep; 278(3):1252-61. PubMed ID: 8819509 [TBL] [Abstract][Full Text] [Related]
18. Effects of histamine, H1- and H2-receptor antagonists on the activity of serotonergic neurons in the dorsal raphe nucleus. Lakoski JM; Aghajanian GK J Pharmacol Exp Ther; 1983 Nov; 227(2):517-23. PubMed ID: 6138428 [TBL] [Abstract][Full Text] [Related]
19. Synthesis and pharmacological investigation of novel 4-(3-ethylphenyl)-1-substituted-4H-[1,2,4]triazolo[4,3-a] quinazolin-5-ones as a new class of H1-antihistaminic agents. Alagarsamy V; Kavitha K; Rupeshkumar M; Solomon VR; Kumar J; Kumar DS; Sharma HK Acta Pharm; 2009 Mar; 59(1):97-106. PubMed ID: 19304562 [TBL] [Abstract][Full Text] [Related]
20. [Studies with experimental bronchospasm (histamine provocation test) for determination of the efficacy of an antihistaminic]. Beumer HM Med Thorac; 1966; 23(4):240-7. PubMed ID: 4381153 [No Abstract] [Full Text] [Related] [Next] [New Search]